PolySialic acid-nanoparticles inhibit macrophage mediated inflammation through Siglec agonism: a potential treatment for age related macular degeneration

Overview of attention for article published in Frontiers in immunology, November 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,359 followers.

RT @avicedarx: The Aviceda Therapeutics team is proud to announce publication of their newest manuscript in the prestigious Frontiers In Im…

21 Nov 2023

Reply Repost Favourite

The Aviceda Therapeutics team is proud to announce publication of their newest manuscript in the prestigious Frontiers In Immunology journal! https://t.co/ZmDamtiiow #glycoimmunology, #biotech, #innovation, #ophthalmology, #retina https://t.co/acb7R4sQ06

20 Nov 2023

Reply Repost Favourite

New Research: PolySialic acid-nanoparticles inhibit macrophage mediated inflammation through Siglec agonism: a potential treatment for age related macular degeneration: Age-related macular degeneration (AMD) is a chronic, progressive retinal… https://t.co/

17 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.